Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGrainger plc Regulatory News (GRI)

Share Price Information for Grainger plc (GRI)

Share Price is delayed by 15 minutes
Get Live Data
150.40    -2.20 (-1.44%)
Bid:
150.90
Ask:
151.10
Spread: 0.20 (0.133%)
Market Cap: £1.11b
GRI Live PriceLast checked at - London Stock Exchange

Intraday Grainger plc Share Chart

Rule 8.3- Grainger PLC

5 Aug 2008 15:20

RNS Number : 7023A
BlackRock Group
05 August 2008
 



FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE

(Rule 8.3 of the City Code on Takeovers and Mergers)

 

1. KEY INFORMATION

Name of person dealing (Note 1)

BlackRock Group

Company dealt in

Grainger Plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

GBP 0.05 ordinary

Date of dealing

4th August 2008 

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

 

(a)

Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

 

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities

3,426,551

2.67%

(2) Derivatives (other than options)

305,912

0.23%

(3) Options and agreements to purchase/sell

Total

3,732,463

2.91%

 

(b)

Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 Class of relevant security: 

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

 

(c) Rights to subscribe (Note 3)

 

Class of relevant security:

Details

3. DEALINGS (Note 4)

 

(a) Purchases and sales

 

Purchase/sale 

Number of securities

Price per unit (Note 5)

Purchase

37,927

GBP 2.00

 (b) Derivatives transactions (other than options)

 

Product name, e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

CFD

Long

12,073

GBP 2.003

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

 

Product name ,e.g. call option 

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price 

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5) 

 

 (ii) Exercising

 

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 5)

 

(d) Other dealings (including new securities) (Note 4)

 

Nature of transaction (Note 8) 

Details

Price per unit (if applicable) (Note 5)

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None……………………………………………………………………

……………………………………………………………………

Is a Supplemental Form 8 attached? (Note 9) NO

 

 

Date of disclosure

5th August 2008

Contact name

Kai Chew

Telephone number

020 7743 2602

If a connected EFM, name of offeree/offeror with which connected

N/A

If a connected EFM, state nature of connection (Note 10)

N/A

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETMGGGRDKLGRZM
Date   Source Headline
23rd Mar 20205:09 pmRNSHolding(s) in Company
10th Mar 20204:24 pmRNSTotal Voting Rights
10th Mar 20207:00 amRNSNotice of Interim Results
6th Mar 202012:11 pmRNSDirector/PDMR Shareholding
3rd Mar 202010:30 amRNSDirector/PDMR Shareholding
24th Feb 20203:22 pmRNSAdditional Listing
18th Feb 202010:47 amRNSHolding(s) in Company
18th Feb 20207:00 amRNSAcquisition
17th Feb 202011:57 amRNSDirector/PDMR Shareholding
13th Feb 20203:53 pmRNSResults of Placing
13th Feb 20207:00 amRNSPlacing to accelerate PRS growth strategy
6th Feb 20203:44 pmRNSDirector/PDMR Shareholding
6th Feb 202012:37 pmRNSDirector/PDMR Shareholding
5th Feb 20203:52 pmRNSResult of AGM
5th Feb 20207:00 amRNSTrading Update
8th Jan 202012:15 pmRNSDirector/PDMR Shareholding
20th Dec 20197:00 amRNSPlanning consent granted in Waterloo, London
12th Dec 20199:43 amRNSDirector/PDMR Shareholding
6th Dec 201912:33 pmRNSDirector/PDMR Shareholding
6th Dec 201912:30 pmRNSTotal Voting Rights
5th Dec 20197:00 amRNSAcquisition of Capital Quarter, Cardiff for c.£57m
3rd Dec 20197:00 amRNSDividend Declaration
28th Nov 20197:00 amRNSAcquisition
27th Nov 20197:00 amRNSFull-year audited financial results
22nd Nov 20193:17 pmRNSHolding(s) in Company
19th Nov 20197:00 amRNSPlanning application submitted Besson St, Lewisham
6th Nov 20194:29 pmRNSDirector/PDMR Shareholding
15th Oct 20197:00 amRNSNotice of Full Year Results
14th Oct 20193:57 pmRNSTotal Voting Rights
7th Oct 20194:41 pmRNSDirector/PDMR Shareholding
2nd Oct 201912:22 pmRNSBlock listing Interim Review
2nd Oct 201912:20 pmRNSBlock listing Interim Review
1st Oct 201911:40 amRNSHolding(s) in Company
30th Sep 201911:18 amRNSDirector/PDMR Shareholding
30th Sep 20197:00 amRNSAcquisition
27th Sep 20197:00 amRNSTrading Update
24th Sep 201911:35 amRNSAdditional Guarantor Notice
24th Sep 201911:28 amRNSGuarantor Resignation Notice
24th Sep 201911:26 amRNSExcluded Entity Resignation Notice
12th Sep 20194:31 pmRNSHolding(s) in Company
12th Sep 201912:21 pmRNSDirector/PDMR Shareholding
10th Sep 20194:00 pmRNSDirector/PDMR Shareholding
6th Aug 20194:27 pmRNSDirector/PDMR Shareholding
6th Aug 20194:26 pmRNSTotal Voting Rights
19th Jul 20197:01 amRNSResponse to Mayor of London's comments
19th Jul 20197:00 amRNSGRIP Portfolio Debt Refinancing
15th Jul 20197:00 amRNSAcquisition Update
9th Jul 20197:00 amRNSAcquisition
8th Jul 201912:49 pmRNSDirector/PDMR Shareholding
3rd Jul 20194:09 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.